mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.3 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |